Quinestrol
CAS No. 152-43-2
Quinestrol ( Estrovis; Ethynyl Estradiol-3-cyclopentyl ether; W 3566 )
Catalog No. M12128 CAS No. 152-43-2
Quinestrol is a synthetic estrogen, used in hormone replacement therapy, and occasionally to treat breast cancer and prostate cancer.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 37 | In Stock |
|
100MG | 53 | In Stock |
|
200MG | 65 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameQuinestrol
-
NoteResearch use only, not for human use.
-
Brief DescriptionQuinestrol is a synthetic estrogen, used in hormone replacement therapy, and occasionally to treat breast cancer and prostate cancer.
-
DescriptionQuinestrol is a synthetic estrogen, used in hormone replacement therapy, and occasionally to treat breast cancer and prostate cancer.
-
SynonymsEstrovis; Ethynyl Estradiol-3-cyclopentyl ether; W 3566
-
PathwayEndocrinology/Hormones
-
TargetEstrogen Receptor/ERR
-
RecptorER
-
Research AreaEndocrinology
-
Indication——
Chemical Information
-
CAS Number152-43-2
-
Formula Weight364.53
-
Molecular FormulaC25H32O2
-
Purity>98%(HPLC)
-
SolubilityWater: 10 mM
-
SMILESCC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC5CCCC5
-
Chemical Name(8R,9S,13S,14S,17R)-3-cyclopentyloxy-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Shyu C, et al. Toxicol Appl Pharmacol. 2010 Nov 12.
molnova catalog
related products
-
Astragaloside IV
Astragaloside IV is generally considered to be the primary active ingredient in Astragalus extract,an herbal extract which has been famous for literally thousands of years for its anti-aging properties.
-
4,4-Iminodiphenol
4,4'-Iminodiphenol is an inactive estrogen receptor ligand with a diphenylamine backbone.
-
Medicarpin
(+)-Medicarpin potently inhibits osteoclastogenesis and promotes bone healing and increases bone mass by osteoblast differentiation with estrogen receptor (ER) β-mediated osteogenic action.